Targeting cellular senescence for cancer therapy.

Area of Science:

• Oncology
• Cellular Biology

Background:

• Cancer remains a major global cause of death, influenced by lifestyle, environmental factors, genetics, and aging.
• Cellular senescence, a state of stable cell cycle arrest, is emerging as a therapeutic target in oncology.
• Harnessing senescence can potentially enhance the effectiveness of existing cancer therapies.

Purpose of the Study:

• To review recent advancements in cancer therapy strategies that target cellular senescence.
• To explore the efficacy of senescence-targeting agents in improving treatment outcomes.
• To discuss the application of senescence induction in preclinical and clinical settings.

Main Methods:

• Literature review of recent studies on senescence targeting in cancer therapy.
• Analysis of preclinical research (in vitro and in vivo) on senescence induction.
• Evaluation of current clinical applications and future prospects of senescence-targeting strategies.

Main Results:

• Senescence-targeting agents demonstrate potential for improving cancer therapy outcomes.
• Preclinical studies show promise in inducing senescence for anticancer effects.
• Clinical translation of these strategies is advancing, though challenges remain.

Conclusions:

• Targeting cellular senescence offers a promising avenue for enhancing anticancer therapy.
• Further preclinical research and clinical trials are needed to optimize senescence-based treatments.
• Successful application could improve chemotherapy efficacy, patient survival, and quality of life.